|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 513/04 | (2006.01) |
| C07C 55/22 | (2006.01) | ||
| C07C 55/10 | (2006.01) | ||
| C07C 55/00 | (2006.01) | ||
| C07C 59/265 | (2006.01) |
| (11) | Number of the document | 3898638 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19842497.0 |
| Date of filing the European patent application | 2019-12-20 | |
| (97) | Date of publication of the European application | 2021-10-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-30 |
| (46) | Date of publication of the claims translation | 2023-11-10 |
| (86) | Number | PCT/US2019/067717 |
| Date | 2019-12-20 |
| (87) | Number | WO 2020/132381 |
| Date | 2020-06-25 |
| (30) | Number | Date | Country code |
| 201862783223 P | 2018-12-21 | US |
| (72) |
SCHLAM, Roxana F. , IL
CUNIERE, Nicolas , US
MBACHU, Victoria A. , US
SHI, Zhongping , US
VLAHOVA, Petinka I. , US
|
| (73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kristalinės PAR4 inhibitoriaus formos |
| CRYSTALLINE FORMS OF A PAR4 INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-11-22 | 6 | 139.00 EUR |
| 2025-12-20 |